FDA NDC Directory · JSON-LD · Markdown

CYRAMZA

NDC 0002-7669 · HUMAN PRESCRIPTION DRUG · SOLUTION

Generic nameramucirumab
Labeler / ManufacturerEli Lilly and Company
Marketing categoryBiologic License Application · App BLA125477
Dosage form / routeSOLUTION · INTRAVENOUS
Active ingredientsRAMUCIRUMAB (10 mg/mL)
Marketing started20140421
Package count1

External sources

Source: openFDA. Public-domain (CC0).